• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Particle Sciences Further Expands Combination Product Development Capabilities

Posted on: Tuesday, 16 June 2009, 13:37 CDT

BETHLEHEM, Pa., June 16 /PRNewswire/ -- Particle Sciences Inc., a leading service provider for the development of thermoplastic based Combination Products (drug-eluting devices), has further expanded their development and pilot production capabilities with the addition of a Leistritz ZSE-18mm twin screw compounding extruder. This expands a compounding, extrusion, pelletization and injection molding line that is suitable for the preparation of high quality Combination Products to support clients' development programs. "With the addition of the Leistritz compounding extruder to our Class 10,000 clean room, Particles Sciences offers development services for thermoplastic Combination Products. We can support such development efforts from concept to clinic," says Dr. Andrew Loxley, Director of New Technologies. Dr. Robert W. Lee, (VP of Pharmaceutical Development) adds, "We are very pleased with the interest we have generated so far. We are now actively working on three Combination Products from different clients, all based on small molecule release from thermoplastics."

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.

Contact: Maureen Cochran mcochran@particlesciences.com +1-610-861-4701

SOURCE Particle Sciences, Inc.

Source: PR Newswire

More News in this Category